Soleno Therapeutics
SLNO
SLNO was delisted on the 15th of May, 2026.
8 hedge funds and large institutions have $1.07M invested in Soleno Therapeutics in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
10% less capital invested
Capital invested by funds: $1.18M → $1.07M (-$112K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$38.1K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$34.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$77K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BG
1
Bollard Group
Boston,
Massachusetts
| $746K | – | – | – |
|
|
BIT
2
BlackRock Institutional Trust
San Francisco,
California
| $139K | – | – | – |
|
|
VKH
3
Virtu KCG Holdings
New York
| $54K | +$34.1K | +233 | +147% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $48K | +$14.5K | +99 | +40% |
|
|
5
UBS Group
Zurich,
Switzerland
| $36K | +$38.1K | +260 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $24K | +$24.9K | +170 | New |
|
|
7
Morgan Stanley
New York
| $18K | -$77K | -526 | -81% |
|
|
BIM
8
BlackRock Investment Management
Wilmington,
Delaware
| $1K | – | – | – |
|
SLNO Hedge Fund Activity: Q4 2015 in Review
8 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q4 2015, worth a combined $1.07M — down 9.5% from $1.18M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SLNO positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $38.1K. The largest seller was Morgan Stanley, cutting an estimated $77K.
- 8 institutional investors held Soleno Therapeutics (SLNO) as of Q4 2015, up from 6 in Q3 2015.
- Funds reported $1.07M of Soleno Therapeutics stock for Q4 2015, down 9.5% quarter-over-quarter.
- 2 funds opened new Soleno Therapeutics positions in Q4 2015 and 0 closed out, a net change of +2 holders.
- The largest Soleno Therapeutics buyer in Q4 2015 was UBS Group, an estimated $38.1K added.
- The largest Soleno Therapeutics seller in Q4 2015 was Morgan Stanley, an estimated $77K sold.
Based on aggregated 13F filings for Q4 2015.